How reduced payments threaten cardiac surgery programs

Across Australia, cardiac surgery units are quietly absorbing the shock of shrinking reimbursement rates. From major metropolitan hospitals in Sydney and Melbourne to regional centres serving vast rural catchments, finance directors and clinical chiefs are confronting a familiar reality: the money coming in no longer matches the cost of running a heart surgery service. Procedures that once broke even now run at a loss, and the gap widens with each successive budget cycle.

The strain is not abstract. It shapes waiting lists for valve replacements, the number of dedicated cardiothoracic theatres a hospital can staff overnight, and whether a rural patient must travel hours for a coronary bypass or have the procedure at all. Cardiology leaders, like those represented through international advocacy networks, have long warned that sustained fee reductions translate directly into fewer available services, a pattern playing out in clinical departments across the country.

Australia's health system mixes universal Medicare coverage with a strong private insurance sector, and both arms are feeling the pressure. When Medicare Benefits Schedule rebates fail to keep pace with the real cost of complex cardiac care, public hospitals absorb the shortfall, while private operators raise gaps or scale back procedural offerings. The result is a tightening squeeze on cardiac surgery programs that communities have relied on for decades.

The funding squeeze facing cardiac units

Cardiothoracic surgery is among the most resource-intensive specialties a hospital can offer. Each operation requires a dedicated theatre, perfusionists, anaesthetists with subspecialty training, intensive care beds, and a roster of nurses competent in post-operative cardiac recovery. When reimbursement rates per case drop, the fixed costs of maintaining this infrastructure do not follow suit; instead, the deficit compounds.

Cost pressure	Public hospital impact	Private hospital impact
Theatre staffing	Reduced operating sessions per week	Higher out-of-pocket fees for patients
Equipment maintenance	Deferred upgrades to bypass machines	Increased gap payments for devices
Subspecialty workforce	Difficulty recruiting perfusionists	Surgeons reducing public sessions
ICU bed allocation	Longer elective surgery waits	Premium coverage costs rising
Training pipelines	Fewer registrar rotations in cardiac surgery	Reduced exposure for advanced trainees

For Australian hospitals, this comparison illustrates a quiet cascade. A hospital in western Sydney may find that its four cardiac theatre sessions per week shrink to two, while a private facility in Adelaide passes rising costs onto the roughly 47 per cent of Australians who hold private hospital cover. The mechanics differ, but the trajectory converges: fewer cardiac operations performed locally, longer waits, and growing pressure on the next hospital down the road.

Why reimbursement cuts hit heart surgery differently

Not every medical specialty responds to a funding cut in the same way. Cardiac surgery carries unique characteristics that make it especially vulnerable. Procedures are long, often spanning four to six hours, and the equipment required, including heart-lung machines, intraoperative monitoring, and sterile consumables, is expensive to maintain and replace. A single valve replacement can consume resources that would fund dozens of less complex interventions.

The workforce is also concentrated. A cardiothoracic surgeon typically trains for more than a decade, and the pool of qualified practitioners is small. When hospital budgets tighten, these highly specialised clinicians are among the first asked to reduce sessions or shift their caseload elsewhere, because their procedural income does not subsidise itself the way a high-volume day surgery might.

There is also a regulatory layer that magnifies the problem. Australian private health insurers negotiate with hospitals using schedules that often reference Medicare Benefits Schedule item numbers, meaning a cut to MBS rebates for cardiac procedures ripples outward into private contracts within months. Hospitals cannot easily renegotiate every agreement when a single funding decision cascades through the entire system in such a compressed timeframe.

Australian hospitals already feeling the pressure

Real examples are emerging. Several regional centres in New South Wales and Queensland have publicly debated whether to maintain on-site cardiac surgery or transfer complex cases to metropolitan hubs in Brisbane, Sydney, or Melbourne. The Royal Australasian College of Surgeons has noted that procedural viability in smaller hospitals is becoming harder to sustain, particularly when anaesthetic and intensive care resources are shared across multiple specialties.

In Western Australia, the distance between Perth and the Pilbara or the Goldfields makes the question more than financial. A patient requiring urgent valve surgery in Kalgoorlie cannot simply be transferred across the continent without risk. Yet the financial model underpinning isolated cardiac services often assumes volumes that smaller populations cannot generate, leaving hospital boards with an uncomfortable choice between clinical safety and fiscal sustainability.

Melbourne's tertiary hospitals continue to perform strongly, but even well-resourced centres report that the proportion of elective cardiac cases completed within recommended timeframes is slipping. Waitlists for coronary artery bypass grafts now stretch into months at several major public hospitals, a delay that affects survival as well as quality of life.

Warning signs that a cardiac program is approaching crisis include:

• A drop in weekly theatre sessions below the level needed to maintain team competence
• Difficulty filling perfusionist or specialist nursing vacancies within three months
• Capital equipment more than a decade old with no replacement scheduled
• Increasing transfer rates of complex cases to other hospitals
• Surgeons reducing their public hospital commitments to maintain income

Patient outcomes when local programs close

The closure of a cardiac surgery program is not merely an administrative change. It reshapes clinical outcomes for thousands of patients. Travel times increase, particularly for elderly Australians and those living with comorbidities that make long-distance transfer risky. The continuity of pre-operative and post-operative care, delivered by the same team in the same hospital, is lost, and that loss has tangible consequences for recovery and complication rates.

Indigenous communities in the Northern Territory and remote Western Australia face disproportionate consequences when specialist services retreat further from their regions. Cultural safety, language, and family support all matter during cardiac recovery, and centralising surgery in capital cities erodes these factors even when the clinical care itself is excellent. A successful operation delivered hundreds of kilometres from home is not always a successful recovery.

Research consistently shows that procedural volume and outcome quality are linked in cardiac surgery. Programs performing fewer than a threshold number of cases annually may see higher complication rates, while centres maintaining high volumes tend to deliver better survival statistics. This creates a difficult tension: smaller programs may already be marginal in clinical terms, yet their absence leaves populations without timely access to life-saving interventions.

Pathways to preserve cardiac services

Several strategies are emerging in response to the funding squeeze. Some hospitals are restructuring their cardiac services around hub-and-spoke models, where metropolitan centres handle complex surgery while regional hospitals focus on diagnostics, rehabilitation, and follow-up care. Others are negotiating bundled-payment arrangements with private insurers that smooth out the volatility of per-procedure rebates and provide predictable revenue streams.

Workforce innovations are also taking shape. Advanced surgical trainees increasingly rotate through regional centres to maintain exposure and contribute to procedural throughput, while nurse practitioner roles in cardiac rehabilitation are helping to free surgical teams for complex cases. Telehealth, expanded rapidly since the pandemic, now supports pre-operative assessment and post-operative review in ways that reduce the need for lengthy travel for routine consultations.

Policy advocacy is gaining momentum. Clinicians, patient groups, and hospital administrators are pressing for a dedicated review of how cardiac procedural rebates are calculated, arguing that current weights undervalue the complexity and team-based nature of modern heart surgery. International advocacy efforts, such as those coordinated through the Campaign for Patient Access, demonstrate that cardiovascular communities worldwide are wrestling with the same structural pressures and that cross-border learning can inform domestic reform.

Practical steps for hospitals and clinicians seeking to safeguard their cardiac programs include:

• Establishing formal networks with metropolitan centres for shared governance and case referral
• Submitting joint funding submissions with neighbouring hospitals to share capital costs
• Engaging private insurers early in conversations about value-based care contracts
• Publishing outcome data transparently to demonstrate program quality and value
• Building community advocacy through patient stories and local media engagement

Why cardiac surgery needs a dedicated funding review

Cardiac surgery deserves a funding framework that reflects its complexity, its team-based delivery, and its life-saving impact. Current Medicare Benefits Schedule weights were designed in a different era, when many cardiac procedures were less invasive and less resource-intensive. Modern practice, including minimally invasive valve surgery, advanced imaging, and longer ICU stays, has outpaced the rebate structure that funds it.

A dedicated review would need to consider not just the rebate per procedure but the network of services that sustain a cardiac program: perfusion, anaesthesia, intensive care, rehabilitation, and follow-up. It would also need to address the geographic reality that a hospital in Cairns or Launceston faces different cost pressures than one in Sydney's eastern suburbs, even when performing identical operations on similar patients.

Without such a review, the trajectory is predictable: marginal programs close, patient travel increases, and the remaining centres absorb higher volumes without commensurate funding. The clinical workforce, already stretched, will continue to drift toward larger centres and private practice, leaving regional and rural Australians with fewer local options. The window for proactive reform is narrowing with each budget cycle.

If you want cardiac surgery services preserved in your community, add your voice to the national conversation. Contact your local federal member, support cardiology patient access initiatives, and share your experiences with the clinical teams who depend on your stories to make the case for continued investment in cardiovascular care.